BUPIVACAINE HYDROCHLORIDE INJECTION, USP
BAXTER CORPORATION
Quick answers
Is there a shortage of BUPIVACAINE HYDROCHLORIDE INJECTION, USP in Canada?
No. There is no current shortage of BUPIVACAINE HYDROCHLORIDE INJECTION, USP 7.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
MARCAINE 0.75% LIQ SPINAL 7.5MG/ML
SANOFI CANADA, INC.
BUPIVACAINE HYDROCHLORIDE INJECTION USP .75%
HOSPIRA HEALTHCARE ULC
MARCAINE 0.75% LIQ PRT 7.5MG/ML
SANOFI CANADA, INC.
SENSORCAINE
ASPEN PHARMACARE CANADA INC.
BUPIVACAINE HYDROCHLORIDE INJECTION USP .50%
HOSPIRA HEALTHCARE ULC
BUPIVACAINE HYDROCHLORIDE INJECTION USP .25%
HOSPIRA HEALTHCARE ULC
DIN
02488930
Strength
7.5MG
Dosage Form
SOLUTION
Route
RETROBULBAR EPIDURAL
Compare with another product →
Shortage History
Other Products from BAXTER CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 00438014
DIN 00786292
DIN 00438049
DIN 00786209
DIN 00437999
DIN 00786217
DIN 00438030
DIN 00438022
DIN 00438006
DIN 00828602
900MG · DIN 00060208
900MG · DIN 00786160